Triple combination of insulin glargine, sitagliptin and metformin in type 2 diabetes: The EASIE post-hoc analysis and extension trial
Journal of Diabetes and its Complications, Volume 29, No. 1, Year 2015
Notification
URL copied to clipboard!
Aim We examined the effects of adding glargine to metformin-sitagliptin (MS + G) or sitagliptin to metformin-glargine (MG + S) therapy in type 2 diabetic persons uncontrolled after 24-week MS or MG dual therapy.